Press Releases

January 22, 2019

23andMe Receives FDA Clearance for Direct-to-Consumer Genetic Test on a Hereditary Colorectal Cancer Syndrome

Clearance allows 23andMe to report on the two most common genetic variants influencing MUTYH-associated polyposis, a hereditary colorectal cancer syndrome.Mountain View, California – January 22, 2019 —23andMe, Inc., the leading…
January 08, 2019

Lark Health and 23andMe Collaborate to Integrate Genetic Information in Two New Health Programs

Lark’s clinically validated AI coaching programs provide new ways for 23andMe customers to take action on their genetic informationMOUNTAIN VIEW, CA – January 8, 2019 – Lark Health, the leader…
October 31, 2018

23andMe Granted the First and Only FDA Authorization For Direct-to-Consumer Pharmacogenetic Reports

The decision allows 23andMe to report directly to customers, without a prescription, the influence their genetics have on how well they metabolize certain medications (Updated Nov. 1, 2018 2:30 PM…